(Q44406427)

2 December 2017

title

5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). (English)

1 reference

2 December 2017

Jason Witherington

1

1 reference

2 December 2017

Vincent Bordas

2

1 reference

2 December 2017

David Haigh

3

1 reference

2 December 2017

Deirdre M B Hickey

4

1 reference

2 December 2017

Robert J Ife

5

1 reference

2 December 2017

Anthony D Rawlings

6

1 reference

2 December 2017

Brian P Slingsby

7

1 reference

2 December 2017

David G Smith

8

1 reference

2 December 2017

Robert W Ward

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

2 December 2017

volume

13

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

1581-1584

1 reference

Biosynthesis of glycogen from uridine diphosphate glucose

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Control of glycogen synthase by hierarchal protein phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Multiple mechanisms for the phosphorylation of C-terminal regulatory sites in rabbit muscle glycogen synthase expressed in COS cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Mechanisms of multisite phosphorylation and inactivation of rabbit muscle glycogen synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Insulin resistance in skeletal muscles in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

A molecular mechanism for the effect of lithium on development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

5-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

Specificity and mechanism of action of some commonly used protein kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900135-5

7 January 2021

10.1016/S0960-894X(03)00135-5

Identifiers

DOI

1 reference

2 December 2017

1 reference